Berenguer, JuanGonzález, JuanPulido Ortega, FedericoPadilla, BelénCasado, José LuisRubio García, RafaelArribas, José Ramón2024-07-312024-07-312002-02-01Berenguer J, González J, Pulido F, Padilla B, Casado JL, Rubio R, Arribas JR; Madrid Group for the Study of Discontinuation of Secondary Prophylaxis in Patients with CMV Retinitis. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy. Clin Infect Dis. 2002 Feb 1;34(3):394-71058-483810.1086/338401https://hdl.handle.net/20.500.14352/107324We performed a prospective study of discontinuation of secondary prophylaxis against cytomegalovirus (CMV) in 36 patients with acquired immunodeficiency syndrome and quiescent CMV retinitis after successful treatment with highly active antiretroviral therapy (HAART). No reactivation or progression of retinitis was observed in 35 patients with persistent response to HAART, findings that support the discontinuation of secondary prophylaxis against CMV retinitis in such patients.engDiscontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapyjournal article1537-6591https://doi.org/10.1086/338401https://academic.oup.com/cid/article/34/3/394/390106restricted access616.98VIHCMV retinitisSecondary ProphylaxisHIVAIDSCiencias Biomédicas24 Ciencias de la Vida